Incorporation of
an electron-withdrawing
−SO2CF3 substituent to cyclometalating
C^N-phenylpyridine (ppy) ligand resulted in an expected blue-shifted
phosphorescence in the corresponding homoleptic Ir(ppySCF
3
)
3
complex,
showing the emission of λem = 464 nm at 300 K. One
of its heteroleptic derivatives, modified by a pyrazolyl borate LX
ligand, Ir(ppySCF
3
)
2
(bor), exhibited further blue-shifted
phosphorescence of λem = 460 nm at 300 K. Cyclic
voltammograms (CVs) and density-functional theory (DFT) calculations
supported the efficacy of the electron-withdrawing capability of the
SO2CF3 substituent lowering HOMO energy and
obtained widened bandgaps and resumed blue emissions for all of the
iridium complexes studied. The homoleptic complexes of both substituents, Ir(ppySCF
3
)
3
and Ir(ppySF)
3
, reached the higher quantum yields (Φ
PL) of (0.89 and 0.72), respectively. Similarly, emission quantum
yields (Φ
PL) of the heteroleptic
derivatives were reported to be (0.75, 0.83, and 0.87) for Ir(ppySCF
3
)
2
(acac), Ir(ppySCF
3
)
2
(bor), and Ir(ppySCF
3
)
2
(pic), respectively. Emission kinetics support the enhanced
quantum efficiency when k
r and k
nr values are compared between Ir(ppySCF
3
)
3
and Ir(ppySF)
3
, and both values favorably
contribute to attaining a higher quantum efficiency for Ir(ppySCF
3
)
3
.
Among solution-processed multilayered devices having an ITO/PEDOT:PSS/TCTA:Ir
dopant (10:1, w/w)/TmPyPB/Liq/Al
structure, a heteroleptic dopant, Ir(ppySCF
3
)
2
(bor), exhibited better device performance, reporting an external quantum
efficiency (EQE) of 1.14%, current efficiency (CE) of 2.31 cd A–1, and power efficiency (PE) of 1.21 lm W–1, together with blue chromaticity of CIEx,y = (0.16, 0.32).